Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phosphorylation of the ribosomal protein RPL12/uL11 affects translation during mitosis

Autor: Imami, K., Milek, M., Bogdanow, B., Yasuda, T., Kastelic, N., Zauber, H., Ishihama, Y., Landthaler, M., Selbach, M.

Emerging evidence indicates that heterogeneity in ribosome composition can give rise to specialized functions. Until now, research mainly focused on differences in core ribosomal proteins and associated factors. The effect of posttranslational modifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=mdc______med::1aaaed56c43724ad6dc839d9d22e3a9c
http://edoc.mdc-berlin.de/17764/1/17764oa.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat.

Autor: Labi V; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria., Peng S; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Klironomos F; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Munschauer M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Kastelic N; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Chakraborty T; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA., Schoeler K; Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria., Derudder E; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.; Institute for Biomedical Ageing Research, University of Innsbruck, Innsbruck 6020, Austria., Martella M; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen 72076, Germany., Mastrobuoni G; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Hernandez-Miranda LR; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Lahmann I; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Kocks C; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Birchmeier C; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Kempa S; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Quintanilla-Martinez de Fend L; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen 72076, Germany., Landthaler M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Rajewsky N; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany., Rajewsky K; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.; Program of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Publikováno v: Genes & development [Genes Dev] 2019 Dec 01; Vol. 33 (23-24), pp. 1673-1687. Date of Electronic Publication: 2019 Nov 07.